Details for New Drug Application (NDA): 089100
✉ Email this page to a colleague
NDA 089100 describes BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, which is a drug marketed by Abraxis Pharm and Hospira and is included in three NDAs. It is available from five suppliers. Additional details are available on the BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER profile page.
The generic ingredient in BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
The generic ingredient in BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
Summary for 089100
| Tradename: | BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER |
| Applicant: | Abraxis Pharm |
| Ingredient: | sterile water for injection |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LIQUID;N/A | Strength | 100% | ||||
| Approval Date: | Dec 29, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
